Chemical shift: The artifact and clinical tool revisited

Radiographics

Volumn 19, Issue 2, 1999, Pages 357-371

  Hood, Maureen N ^a   Ho, Vincent B ^a   Smirniotopoulos, James G ^a   Szumowski, Jerzy ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Magnetic resonance (MR), artifacts; Magnetic resonance (MR), chemical shift; Magnetic resonance (MR), tissue characterization

Indexed keywords

LIPID; PROTON;

ARTIFACT; BODY WATER; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PHYSICS; REVIEW;

ARTIFACTS; BODY WATER; CHEMISTRY, PHYSICAL; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING; PHYSICS; PROTONS;

EID: 0033090412     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.19.2.g99mr07357     Document Type: Article

References (44)

1. Rholl KS, Lee JKT, Heiken JP, Ling D, Glazer HS. Primary bladder carcinoma: evaluation with MR imaging. Radiology 1987; 163:117-121.
2. Simon JH, Foster TH, Ketonen L, et al. Reduced-bandwidth MR imaging of the head at 1.5 T. Radiology 1989; 172:771-775.
3. Herrick RC, Hayman LA, Taber KH, Diaz-Marchan PJ, Kuo MD. Artifacts and pitfalls in MR imaging of the orbit: a clinical review. RadioGraphics 1997; 17:707-724.
4. Rofsky NM, Weinreb JC, Ambrosino MM, Safir J, Krinsky G. Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 1996; 20:230-235.
5. Szumowski J, Simon JH. Proton chemical shift imaging. In: Stark D, Bradley W, eds. Magnetic resonance imaging. St Louis, Mo: Mosby-Year Book, 1994; 479-521.
6. Babcock EE, Brateman L, Weinreb JC, Horner SD, Nunnally RL. Edge artifacts in MR images: chemical shift effect. J Comput Assist Tomogr 1985; 9:252-257.
7. Brateman L. Chemical shift imaging: a review. AJR 1986; 146:971-980.
8. Simon JH, Szumowski J. Proton (fat/water) chemical shift imaging in magnetic resonance imaging. Invest Radiol 1992; 27:865-874.
9. Parizel PM, van Hasselt BAAM, van den Hauwe L, Van Goethem JWM, De Schepper AMA. Understanding chemical shift induced boundary artefacts as a function of field strength: influence of imaging parameters (bandwidth, field-of-view, and matrix size). Eur J Radiol 1994; 18:158-164.
10. Smith AS, Weinstein MA, Hurst GC, DeRemer DR, Cole RA, Duchesneau PM. Intracranial chemical-shift artifacts on MR images of the brain: observations and relation to sampling bandwidth. AJR 1990; 154:1275-1283.
11. Edelman RR, Hesselink JR, Zlatkin MB. Clinical magnetic resonance imaging. Philadelphia, Pa: Saunders, 1996.
12. Smith RC, Lange RC, McCarthy SM. Chemical shift artifact: dependence on shape and orientation of the lipid-water interface. Radiology 1991; 181:225-229.
13. Mitchell DG. Chemical shift magnetic resonance imaging: applications in the abdomen and pelvis. Top Magn Reson Imaging 1992; 4:46-63.
14. Wehrli FW, Perkins TG, Shimakawa A, Roberts F. Chemical shift-induced amplitude modulations in images obtained with gradient refocusing. Magn Reson Imaging 1987; 5:157-158.
15. Lee HK, Nalcioglu O, Buxton RB. Correction for chemical-shift artifacts in 19F imaging of PFOB: simultaneous multislice imaging. Magn Reson Med 1991; 21:21-29.
16. Dooms GC, Hricak H, Sollitto RA, Higgins CB. Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. Radiology 1985; 157:479-483.
17. Truwit CL, Barkovich AJ. Pathogenesis of intracranial lipoma: an MR study in 42 patients. AJR 1990; 155:855-864.
18. Eghwrudjakpor PO, Kurisaka M, Fukuoka M, Mori K. Intracranial lipomas: current perspectives in their diagnosis and treatment. Br J Neurosurg 1992; 6:139-144.
19. Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991; 179:199-206.
20. Bradley WG. MR appearance of hemorrhage in the brain. Radiology 1993; 189:15-26.
21. Smirniotopoulos JG, Chiechi MV. Teratomas, dermoids, and epidermoids of the head and neck. RadioGraphics 1995; 15:1437-1455.
22. Zee C, Segall H, Apuzzo M, et al. MR imaging of pineal region neoplasms. J Comput Assist Tomogr 1991; 15:56-63.
23. Martin J, Sentis M, Zidan A, Donosol L, Puig J, Falco J, Bela R. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 1995; 195:125-130.
24. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1992; 185:1-11.
25. Mitchell DG, Palazzo J, Hann HYL, Rifkin MD, Burk DL, Rubin R. Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 1991; 15:762-769.
26. Hoyumpa AM, Greene HL, Dunn GD, Schenker S. Fatty liver: biochemical and clinical considerations. AmJ Dig Dis 1975; 20:1142-1170.
27. Lewis E, Bernardino ME, Barnes PA, Parvey HR, Soo CS, Chuang VP. The fatty liver: pitfalls in the CT and angiographic evaluation of metastatic disease. J Comput Assist Tomogr 1983; 7:235-241.
28. Mitchell DG, Kim I, Chang TS, et al. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991; 26: 1041-1052.
29. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351.
30. Krestin GP. Magnetic resonance imaging of the kidneys: current status. Magn Reson Q 1994; 10: 2-21.
31. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1993; 186:705-709.
32. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR 1995; 164:637-642.
33. Cutwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR 1995; 165:579-583.
34. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995; 197:411-418.
35. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuated value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200:749-752.
36. Schwartz LH, Panicek DM, Koutcher JA, et al. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging. Radiology 1995; 197:421-425.
37. Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989; 171:675-680.
38. Leroy-Willig A, Bittoun J, Luton JP, et al. In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. AJR 1989; 153:771-773.
39. McNichols MMJ, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR 1995; 165: 1453-1459.
40. Mayo-Smith WW, Lee MJ, McNichols MMJ, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165:91-95.
41. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200:743-747.
42. Reinig JW, Stutley JE, Leonhardt CM, Spicer KM, Margolis M, Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994; 192:41-46.
43. Shifrin RY, Bechtold RE, Scharling ES. Metastatic adenocarcinoma within an adrenal adenoma: detection with chemical shift imaging. AJR 1996; 167:891-892.
44. Mitchell DG, Stolpen AH, Siegelman ES, Bolinger L, Outwater EK. Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents. Radiology 1996; 198:351-357.